文献速递消化道肿瘤与早癌消化内镜

内镜黏膜下剥离术治疗早期食管腺癌:低分化黏膜癌转移率低

Endoscopic submucosal dissection for early esophageal adenocarcinoma: low rates of metastases in mucosal cancers with poor differentiation.
PubMed 文献 · Gastrointest Endosc · 2024-03-11

本研究纳入16家德国中心接受内镜黏膜下剥离术的早期食管腺癌患者,分析低分化且R0切除并内镜随访者的临床病程。单危险因素低分化组25例转移率4.0%,合并其他危险因素组15例转移率20.0%(P=0.293)。中位随访30个月,单危险因素低分化黏膜癌内镜切除后转移风险低。

要点

  • 单危险因素低分化黏膜食管腺癌内镜切除后转移率4.0%(1/25)。
  • 低分化合并黏膜下浸润和/或淋巴血管浸润者转移率20.0%(3/15)。
  • 两组转移率比较P=0.293,中位随访30个月。

核心结论

  • 长期随访中,以低分化为单一危险因素的黏膜食管腺癌内镜切除后转移风险低。
  • 在这一小样本患者群中,保守处理似乎是合理的。
  • 在获得进一步前瞻性数据之前,治疗策略必须个体化决定。

研究设计与样本

  • 回顾性分析前瞻性收集的数据库,纳入16家德国中心接受内镜黏膜下剥离术的食管腺癌患者。
  • 纳入标准为切除标本低分化、R0切除并接受内镜随访。
  • 主要结局为随访期间的转移率。

主要发现

  • A组(低分化单一危险因素)25例,转移1例(4.0%;95%CI,0.4%-17.2%)。
  • B组(低分化合并黏膜下浸润和/或淋巴血管浸润)15例,转移3例(20.0%;95%CI,6.0%-44.4%)。
  • 两组转移率比较P=0.293。
  • 食管腺癌相关死亡率A组1/25(4%;95%CI,0.4%-17.2%),B组3/15(20%;95%CI,6.0%-44.4%),P=0.293。
  • 总死亡率A组7/25(28.0%;95%CI,13.5%-47.3%),B组3/15(20%;95%CI,6.0%-44.4%),P=0.715;中位随访30个月(四分位距15-53个月)。

关键数值与推荐

  • 低分化为单一危险因素的黏膜食管腺癌内镜切除后转移率4.0%(95%CI,0.4%-17.2%)。
  • 低分化合并黏膜下浸润和/或淋巴血管浸润者转移率20.0%(95%CI,6.0%-44.4%)。

临床怎么用

  • 作者认为,在这一小样本患者群中保守处理似乎是合理的。
  • 作者认为,在获得进一步前瞻性数据之前治疗策略必须个体化决定。

局限性

  • 分析为回顾性,数据库为前瞻性收集。
  • 样本量小(A组25例,B组15例)。
  • 原文结论指出需进一步前瞻性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic resection is accepted as standard treatment for intramucosal esophageal adenocarcinoma (EAC) that is well or moderately differentiated. Poor differentiation (PD) is judged as a risk factor for lymph node metastasis (LNM), and surgery is recommended. However, the evidence for this recommendation is weak. The aim of this study was to analyze the clinical course of patients after endoscopic resection of EAC with PD. METHODS: Patients undergoing endoscopic submucosal dissection for EAC were included from 16 German centers. Inclusion criteria were PD in the resection specimen, R0 resection, and endoscopic follow-up. Primary outcome was the metastasis rate during follow-up. Analysis was performed retrospectively in a prospectively collected database. RESULTS: Twenty-five patients with PD as single risk factor (group A) and 15 patients with PD and additional risk factors (submucosal invasion and/or lymphovascular invasion) (group B) were included. The metastasis rate was was 1 of 25 (4.0%; 95% CI, .4%-17.2%) in group A and 3 of 15 (20.0%; 95% CI, 6.0%-44.4%) in group B, respectively (P = .293). The rate of EAC-associated deaths was 1 of 25 (4%; 95% CI, .4%-17.2%) versus 3 of 15 (20%; 95% CI, 6.0%-44.4%) in group B (P = .293). The overall death rate was 7 of 25 (28.0%; 95% CI, 13.5%-47.3%) versus 3 of 15 (20%; 95% CI, 6.0%-44.4%) (P = .715). Median follow-up was 30 months (interquartile range, 15-53 months). CONCLUSIONS: During long-term follow-up, the risk of metastasis is low after endoscopic resection of mucosal EAC with PD as a single risk factor. A conservative approach seems justified in this small patient group. However, the treatment strategy must be determined on an individualized basis until further prospective data are available.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Probst A, Kappler F, Ebigbo A, et al. Endoscopic submucosal dissection for early esophageal adenocarcinoma: low rates of metastases in mucosal cancers with poor differentiation. Gastrointest Endosc. 2024. PMID: 38479623. doi:10.1016/j.gie.2024.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。